@article {4888,
	title = {Effect of the CCR5 antagonist maraviroc on the occurrence of immune reconstitution inflammatory syndrome in HIV (CADIRIS): a double-blind, randomised, placebo-controlled trial.},
	journal = {The lancet. HIV},
	volume = {1},
	year = {2014},
	month = {2014 Nov},
	pages = {e60-7},
	abstract = {Immune reconstitution inflammatory syndrome (IRIS) is a common complication of antiretroviral therapy (ART) in patients with HIV. IRIS is associated with an increased risk of admission to hospital and death. We assessed whether CCR5 blockade with maraviroc reduces the risk of IRIS.},
	issn = {2352-3018},
	doi = {10.1016/S2352-3018(14)70027-X},
	author = {Sierra-Madero, Juan G and Ellenberg, Susan S and Rassool, Mohammed S and Tierney, Ann and Belaunzar{\'a}n-Zamudio, Pablo F and L{\'o}pez-Mart{\'\i}nez, Alondra and Pi{\~n}eir{\'u}a-Men{\'e}ndez, Alicia and Montaner, Luis J and Azzoni, Livio and Ben{\'\i}tez, C{\'e}sar Rivera and Sereti, Irini and Andrade-Villanueva, Jaime and Mosqueda-G{\'o}mez, Juan L and Rodriguez, Benigno and Sanne, Ian and Lederman, Michael M}
}
